维普中文期刊产品整合服务
88篇 您的检索式:作者名="Gore ME"
    题名 作者 年代 出处 被引量
1Safety and efficacy of subcutaneous and continuous intravenous itffusion rlL-2 in patients with metastatic renal cell carcinoma 显示文摘Geertsen PF Gore ME Negrier S 2004Br J Cancer2004,90,6:1
2Mucinous ovariancancer显示文摘Harrison ML Jameson C Gore ME 2008Int J Gynecol Cancer2008,18,2:1
3Hepatocyte death: a clear and present danger显示文摘Malhi H Guicciardi ME Gores GJ 2010Physiol Rev2010,90,3:1
4Safety and efficacy of sunitinib for metastatic renal - cell carcinoma: an expanded - access trial 显示文摘Gore ME Szczylik C Porta C 2009The lancet oncology2009,10,8:1
5Emerging efficacy endpoints for targeted therapies in advanced renal celt carcinoma 显示文摘Gore ME Escudier B 2006Oncology2006,20,65:1
6A randomised, phase II trial of the DNA - hypomethylating agent 5 - aza - 2'- deoxycytidine ( decit- abine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum - sensitive ovarian cancer 显示文摘Glasspool RM Brown R Gore ME 2014Br J Cancer2014,110,8:1
7Safety and efficacy of sunitinibfor metastatic renal - cell carcinoma : an expanded - access trial显示文摘Gore ME Szczylik C Lee E 2009Lancet Oncol2009,10,8:1
8Neoadjuvant chemotherapy for locally advanced cervical cancer显示文摘Timotheadou E Gore ME 2003Eur J Cancer2003,39,17:1
9Apoptosis: a mechanism of a- cute and chronic liver injury 显示文摘Guiceiardi ME Gores GJ 2005Gut2005,54,:1
10Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase Ⅰ/Ⅱ study显示文摘BUKOWSKI R ERNSTOFF MS GORE ME 2002J Clin Oncol2002,20,18:1
11Apoptosis as a mechanism for liver disease progression显示文摘Guicciardi ME Gores GJ 2010Semin Liver Dis2010,30,4:1
12Safety and efficacy of sunitinib for metastatic renal-cell carcinoma : An expanded-access trial 显示文摘Gore ME Szczylik C Porta C 2009Lancet Oncol2009,10,8:1
13Safety and effi-cacy of sunitinib formetastatic renal-cell carcinoma:an ex-panded access trial显示文摘GORE ME SZCZYLIK C PORTA C 2009Lancet Oncol2009,10,8:1
14Life and death by death receptors显示文摘Guicciardi ME Gores GJ 2009FASEB J2009,23,6:1
15Safety and efficacy of sunitinib for metastatic renal - cell carcinoma: An expanded - access trial显示文摘Gore ME Szczylik C Porta C 2009Lancet Oncol2009,10,8:1
16Apoptosis as a mechanism for liver disease progression 显示文摘Guicciardi ME Gores GJ 2010Semin Liver Dis2010,30,4:1
17Changes in sexual behavior among HIV-infected women alter initiation of HAART显示文摘Wilson TE Gore ME Greenhlatt R 2004Am J Public Health Jul2004,94,7:1
18Unexpected toxicity of combination thalidomide and interferon a -2a treatment in metastatic renal cell carcinoma显示文摘Nathan PD Gore ME Eisen TG 2002J Clin Oncol2002,20,:1
19Intnsive treatment of multiple myeloma and criteria for complete remission显示文摘Gore ME Selby PJ Viner C 1989Lancet1989,2,8668:1
20Apoptosis: a mechanism of acute and chronic liver injury显示文摘ME Guicciardi GJ Gores 2005GUT2005,54,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费